UBE2T And CYP3A4: hub genes regulating the transformation of cirrhosis into hepatocellular carcinoma

References

• Alpi A, Langevin F, Mosedale G, Machida YJ, Dutta A, Patel KJ. 2007. UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol Cell Biol. 27(24):8421–8430.
   PubMed Web of Science ®Google Scholar
• Alpi AF, Pace PE, Babu MM, Patel KJ. 2009. Mechanistic insight into site-restricted monoubiquitination of FANCD2 by UBE2T, FANCL, and FANCI. Mol Cell. 32(6):767–777.
   Web of Science ®Google Scholar
• Archer KJ, Mas VR, David K, Maluf DG, Bornstein K, Fisher RA. 2009. Identifying genes for establishing a multigenic test for hepatocellular carcinoma surveillance in hepatitis C virus-positive cirrhotic patients. Cancer Epidemiol Biomarkers Prev. 18(11):2929–2932.
   Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. 2000. Gene ontology: tool for the unification of biology. Nat Genet. 25(1):25–29.
   PubMed Web of Science ®Google Scholar
• Augustin E, Pawłowska M, Polewska J, Potega A, Mazerska Z. 2013. Modulation of CYP3A4 activity and induction of apoptosis, necrosis and senescence by the anti-tumour imidazoacridinone C-1311 in human hepatoma cells. Cell Biol Int. 37(2):109–120.
   Web of Science ®Google Scholar
• Ayed-Boussema I, Pascussi JM, Maurel P, Bacha H, Hassen W. 2012. Effect of aflatoxin B1 on nuclear receptors PXR, CAR, and AhR and their target cytochromes P450 mRNA expression in primary cultures of human hepatocytes. Int J Toxicol. 31(1):86–93.
   Web of Science ®Google Scholar
• Bader GD, Hogue CW. 2003. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 4:2.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, Stravitz RT, Luketic V, Fuchs M, White MB, et al. 2011. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 106(9):1646–1653.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. 2017. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 169(7):1327–1341.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. 2012. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2:401–404.
   PubMed Web of Science ®Google Scholar
• Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al. 2002. Gene expression patterns in human liver cancers. Mol Biol Cell. 13(6):1929–1939.
   PubMed Web of Science ®Google Scholar
• Chen QF, Xia JG, Li W, Shen LJ, Huang T, Wu P. 2018. Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus-positive cirrhosis. Mol Med Rep. 18(6):4940–4950.
   Web of Science ®Google Scholar
• Darpolor MM, Basu SS, Worth A, Nelson DS, Clarke-Katzenberg RH, Glickson JD, Kaplan DE, Blair IA. 2014. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and 13C-isotope based metabolomics. NMR Biomed. 27(4):381–389.
   Web of Science ®Google Scholar
• David Y, Ziv T, Admon A, Navon A. 2010. The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. J Biol Chem. 285(12):8595–8604.
   PubMed Web of Science ®Google Scholar
• Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30(1):207–210.
   PubMed Web of Science ®Google Scholar
• El-Merhibi A, Ngo SN, Marchant CL, Height TA, Stupans I, McKinnon RA. 2012. Cytochrome P450 CYP3A in marsupials: cloning and identification of the first CYP3A subfamily member, isoform 3A70 from Eastern gray kangaroo (Macropus giganteus). Gene. 506(2):423–428.
   Web of Science ®Google Scholar
• Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. 2018. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 67(1):123–133.
   PubMed Web of Science ®Google Scholar
• Fanni D, Fanos V, Ambu R, Lai F, Gerosa C, Pampaloni P, Van Eyken P, Senes G, Castagnola M, Faa G. 2015. Overlapping between CYP3A4 and CYP3A7 expression in the fetal human liver during development. J Matern Fetal Neonatal Med. 28(11):1291–1295.
   PubMed Web of Science ®Google Scholar
• Fan W, Ye G. 2018. Microarray analysis for the identification of specific proteins and functional modules involved in the process of hepatocellular carcinoma originating from cirrhotic liver. Mol Med Rep. 17(4):5619–5626.
   Web of Science ®Google Scholar
• Fanni D, Manchia M, Lai F, Gerosa C, Ambu R, Faa G. 2016. Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma. Eur J Histochem. 60(2):81–85.
   Web of Science ®Google Scholar
• Fujimura T, Takahashi S, Urano T, Tanaka T, Zhang W, Azuma K, Takayama K, Obinata D, Murata T, Horie-Inoue K, et al. 2012. Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer. Cancer Sci. 103(2):176–180.
   Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. 2013. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 6(269):pl1.
   PubMed Web of Science ®Google Scholar
• Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, Huang C, Li J, Dong X, Zhou Y, et al. 2019. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell. 179(5):561–577.
   Web of Science ®Google Scholar
• Giacomo D, Engle RE, Ashley T, Melis M, Montenegro S, Rodriguez-Canales J, Hanson J, Emmert-Buck MR, Bock KW, Moore IN, et al. 2018. Molecular signature and mechanisms of hepatitis D virus–associated hepatocellular carcinoma. Mol Cancer Res. 16(9):1406–1419.
   Web of Science ®Google Scholar
• Goldman M, Craft B, Brooks A, Mcdade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, Zhu J. 2018. The UCSC Xena platform for public and private cancer genomics data visualization and interpretation. bioRxiv.
   Google Scholar
• Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, et al. 2012. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 44(6):694–698.
   PubMed Web of Science ®Google Scholar
• Guo XG, Wang ZH, Dong W, He XD, Liu FC, Liu H. 2018. Specific CYP450 genotypes in the Chinese population affect sorafenib toxicity in HBV/HCV-associated hepatocellular carcinoma patients. Biomed Environ Sci. 31(8):586–595.
   Web of Science ®Google Scholar
• Haas S, Merkelbach-Bruse S, Justenhoven C, Brauch H, Fischer HP. 2009. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver. Pathol Res Pract. 205(10):716–725.
   Web of Science ®Google Scholar
• He B, Yin J, Gong S, Gu J, Xiao J, Shi W, Ding W, He Y. 2017. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis. Medicine (Baltimore). 96(25):e6938.
   Web of Science ®Google Scholar
• Hu W, Xiao L, Cao C, Hua S, Wu D. 2016. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway. Oncotarget. 7(12):15161–15172.
   PubMedGoogle Scholar
• Huang DW, Sherman BT, Lempicki RA. 2009a. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37(1):1–13.
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Lempicki RA. 2009b. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4(1):44–57.
   PubMed Web of Science ®Google Scholar
• Jiang CH, Yuan X, Li JF, Xie YF, Zhang AZ, Wang XL, Yang L, Liu CX, Liang WH, Pang LJ, et al. 2020. Bioinformatics–based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma. J Transl Med. 18(1):40.
   Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. 2016. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44:457–462.
   PubMed Web of Science ®Google Scholar
• Karakurt S. 2016. Modulatory effects of rutin on the expression of cytochrome P450s and antioxidant enzymes in human hepatoma cells. Acta Pharm. 66(4):491–502.
   Web of Science ®Google Scholar
• Li L, Lei Q, Zhang S, Kong L, Qin B. 2017. Screening and identification of key biomarkers in hepatocellular carcinoma: evidence from bioinformatic analysis. Oncol Rep. 38(5):2607–2618.
   PubMed Web of Science ®Google Scholar
• Li YL, Zheng MX, Wang G. 2016. A personalized approach identifies disturbed pathways and key genes in hepatitis C virus–cirrhosis with hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 20(20):4266–4273.
   Web of Science ®Google Scholar
• Liu LP, Yang M, Peng QZ, Li MY, Zhang YS, Guo YH, Chen Y, Bao SY. 2017. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53. Biochem Biophys Res Commun. 493(1):20–27.
   PubMed Web of Science ®Google Scholar
• Liu LL, Zhu JM, Yu XN, Zhu HR, Shi X, Bilegsaikhan E, Guo HY, Wu J, Shen XZ. 2019. UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma. Cancer Manag Res. 11:8359–8370.
   PubMed Web of Science ®Google Scholar
• Longerich S, San Filippo J, Liu D, Sung P. 2009. FANCI binds branched DNA and is monoubiquitinated by UBE2T-FANCL. J Biol Chem. 284(35):23182–23186.
   Web of Science ®Google Scholar
• Machida YJ, Machida Y, Chen Y, Gurtan AM, Kupfer GM, D'Andrea AD, Dutta A. 2006. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell. 23(4):589–596.
   PubMed Web of Science ®Google Scholar
• Maere S, Heymans K, Kuiper M. 2005. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics. 21(16):3448–3449.
   PubMed Web of Science ®Google Scholar
• Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P, Fisher R. 2009. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med. 15:85–94.
   PubMed Web of Science ®Google Scholar
• Morreale FE, Bortoluzzi A, Chaugule VK, Arkinson C, Walden H, Ciulli A. 2017. Allosteric targeting of the Fanconi anemia ubiquitin-conjugating enzyme UBE2T by fragment screening. J Med Chem. 60(9):4093–4098.
   PubMed Web of Science ®Google Scholar
• Niu Y, Wu Z, Shen Q, Song J, Luo Q, You H, Shi G, Qin W. 2013. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis. Dig Liver Dis. 45(12):1041–1048.
   Google Scholar
• Patel AA, Walling AM, Ricks-Oddie J, May FP, Saab S, Wenger N. 2017. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 15(10):1612–1619.
   Web of Science ®Google Scholar
• Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, Wang XW. 2010. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 70(24):10202–10212.
   PubMed Web of Science ®Google Scholar
• Sakai Y, Honda M, Fujinaga H, Tatsumi I, Mizukoshi E, Nakamoto Y, Kaneko S. 2008. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients. Cancer Res. 68(24):10267–10279.
   PubMed Web of Science ®Google Scholar
• Sartorius K, Sartorius B, Aldous C, Govender PS, Madiba TE. 2015. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiol. 39(3):284–290.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Afdhal NH. 2008. Liver cirrhosis. Lancet. 371(9615):838–851.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. 2019. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47:607–613.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. 2017. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45:98–102.
   PubMed Web of Science ®Google Scholar
• Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. 2015. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 62(2):584–590.
   PubMed Web of Science ®Google Scholar
• Tapper EB, Parikh ND. 2018. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. Br Med J. 362:k2817.
   PubMedGoogle Scholar
• Torrecilla S, Sia D, Harrington AN, Zhang Z, Cabellos L, Cornella H, Moeini A, Camprecios G, Leow WQ, Fiel MI, et al. 2017. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma. J Hepatol. 67(6):1222–1231.
   PubMed Web of Science ®Google Scholar
• Ueki T, Park JH, Nishidate T, Kijima K, Hirata K, Nakamura Y, Katagiri T. 2009. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 69(22):8752–8760.
   PubMed Web of Science ®Google Scholar
• Villanueva A. 2019. Hepatocellular carcinoma. N Engl J Med. 380(15):1450–1462.
   PubMed Web of Science ®Google Scholar
• Villanueva A, Portela A, Sayols S, Battiston C, Hoshida Y, Méndez-González J, Imbeaud S, Letouzé E, Hernandez-Gea V, Cornella H, et al. 2015. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. Hepatology. 61(6):1945–1956.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jiang T, Li Z, Lu L, Zhang R, Zhang D, Wang X, Tan J. 2017. Analysis of differentially co-expressed genes based on microarray data of hepatocellular carcinoma. Neoplasma. 64(2):216–221.
   Web of Science ®Google Scholar
• Wei X, You X, Zhang J, Zhou C. 2019. MicroRNA-1305 inhibits the stemness of LCSCs and tumorigenesis by repressing the UBE2T-dependent Akt-signaling pathway. Mol Ther Nucleic Acids. 16:721–732.
   PubMedGoogle Scholar
• Wu M, Liu Z, Li X, Zhang A, Lin D, Li N. 2019. Analysis of potential key genes in very early hepatocellular carcinoma. World J Surg Oncol. 17(1):77.
   Google Scholar
• Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et al. 2007. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 45(4):938–947.
   PubMed Web of Science ®Google Scholar
• Xie F, Zhu F, Lu Z, Liu Z, Wang H. 2016. Investigation of potential molecular biomarkers and small molecule drugs for hepatocellular carcinoma transformed from cirrhosis. Oncol Lett. 12(1):495–503.
   Web of Science ®Google Scholar
• Yildiz G, Arslan-Ergul A, Bagislar S, Konu O, Yuzugullu H, Gursoy-Yuzugullu O, Ozturk N, Ozen C, Ozdag H, Erdal E, et al. 2013. Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis. PLoS One. 8(5):e64016.
   Web of Science ®Google Scholar
• Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 138(1):103–141.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhuo C, Zhou D, Zhang F, Chen M, Xu S, Chen Z. 2019. Association between the expression of carbonic anhydrase II and clinicopathological features of hepatocellular carcinoma. Oncol Lett. 17(6):5721–5728.
   PubMed Web of Science ®Google Scholar